Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1995-04-27
1999-07-20
Carlson, Karen C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
536 2372, 536 241, 530300, 530350, C12Q 168, C07H 1700, C07K 1400
Patent
active
059255161
ABSTRACT:
Medicaments, and methods of identifying the same, are described that are useful for treating papillomavirus diseases that have the characteristics of preventing, interfering with, or reversing the binding of the appropriate papillomavirus proteins E1 or E2 to a nucleotide sequence homologous to a nucleotide sequence present in the papillomavirus genome, or of the formation of a complex consisting of papillomavirus proteins E1 and E2, or the binding of the complex to the nucleotide sequence.
REFERENCES:
patent: 5620849 (1997-04-01), Botchan et al.
Schiller et al. 1989 J Virol. 63(4): 1775-1782.
Lambert et al. 1988 J Virol 62 (11): 4009-4015.
Blitz et al. "The 68-Kilodalton E1 Protein of Bovine Papillomavirus Is a DNA Binding Phosphoprotein Which Associates with the E2 Transcriptional Activator in Vitro" (1991) J. Virol. 65(2):649-656.
Chiang et al. "An E1M+E2C Fusion Protein Encoded by Human Papillomavirus Type 11 Is a Sequence-Specific Transcription Repressor"(1991) J. Virol. 65(6):3317-3329.
Knight et al. "The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops" (1991) Proc. Natl. Acad. Sci. USA 88:3204-3208 (copy enclosed).
Lambert et al. "Bovine Papillomavirus Type 1 E1 Replication-Defective Mutants are Altered in Their Transcriptional Regulation" (1988) J. Virol. 62:4009-4015.
Mohr et al. "Targeting the E1 Replication Protein to the Papillomavirus Origin of Replication by Complex Formation with the E2 Transactivator" (1990) Science 250:1694-1699.
Schiller et al. "Identification of Bovine Papillomavirus E1 Mutants with Increased Transforming and Transcriptional Activity"(1989) J. Virol. 63:1775-1782.
Sekine et al. "Expression of human papillomavirus type 6b E2 gene product with DNA-binding activity in insect (Bombyx mori) cells using a baculovirus expression vector" (1988) Gene 65:187-193.
Sun et al. "Identification of a 68-Kilodalton Nuclear ATP-Binding Phosphoprotein Encorded by Bovine Papillomavirus Type 1" (1990) J. Virol. 64:5093-5105 (copy enclosed).
Yang et al. "Replication of Bovine Papillomavirus Type 1 DNA Initiates within an E2-Responsive Enhancer Element" (1990) J. Virol. 64:5903-5911 (copy enclosed).
Botchan Michael R.
Clark Robin
Mohr Ian J.
Sun Shaw
Blackburn Robert P.
Carlson Karen C.
Chiron Corporation
McCracken Thomas P.
University of California
LandOfFree
Medicaments for the treatment of papillomavirus diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments for the treatment of papillomavirus diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the treatment of papillomavirus diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321258